Antinori A - Search Results

1

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison.

Gagliardini R, Cozzi-Lepri A, Mariano A, Taglietti F, Vergori A, Abdeddaim A, Di Gennaro F, Mazzotta V, Amendola A, D'Offizi G, Palmieri F, Marchioni L, Piselli P, Agrati C, Nicastri E, Capobianchi MR, Petrosillo N, Ippolito G, Vaia F, Girardi E, Antinori A. Gagliardini R, et al. Among authors: antinori a. Front Pharmacol. 2021 Apr 22;12:621676. doi: 10.3389/fphar.2021.621676. eCollection 2021. Front Pharmacol. 2021. PMID: 33967755 Free PMC article.

2

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.

Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G, Amendola A, Capobianchi M, Tozzi V, Perno CF. Antinori A, et al. AIDS. 2002 Sep 27;16(14):1867-76. doi: 10.1097/00002030-200209270-00003. AIDS. 2002. PMID: 12351946

3

High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy.

Girardi E, Palmieri F, Zaccarelli M, Tozzi V, Trotta MP, Selva C, Narciso P, Petrosillo N, Antinori A, Ippolito G. Girardi E, et al. Among authors: antinori a. AIDS. 2002 Sep 27;16(14):1976-9. doi: 10.1097/00002030-200209270-00021. AIDS. 2002. PMID: 12351964 No abstract available.

4

Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).

Amendola A, Bordi L, Angeletti C, Visco-Comandini U, Abbate I, Cappiello G, Budabbus MA, Eljhawi OA, Mehabresh MI, Girardi E, Antinori A, Ippolito G, Capobianchi MR. Amendola A, et al. Among authors: antinori a. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):488-94. doi: 10.1097/00126334-200212150-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12473837

5

Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy.

Liuzzi G, D'Offizi G, Topino S, Zaccarelli M, Amendola A, Capobianchi MR, Perno CF, Narciso P, Antinori A. Liuzzi G, et al. Among authors: antinori a. AIDS. 2003 May 2;17(7):1089-92. doi: 10.1097/00002030-200305020-00022. AIDS. 2003. PMID: 12700463

6

HIV Type 1 replication in cerebrospinal fluid of patients with AIDS-related non-Hodgkin's lymphoma receiving chemotherapy and antiretroviral therapy.

Giancola ML, Uccella I, Alba L, Lorenzini P, Soldani F, Capobianchi M, Ruco L, Perno CF, Antinori A. Giancola ML, et al. Among authors: antinori a. AIDS Res Hum Retroviruses. 2003 Dec;19(12):1091-5. doi: 10.1089/088922203771881185. AIDS Res Hum Retroviruses. 2003. PMID: 14709245

7

Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders.

Abbate I, Cappiello G, Longo R, Ursitti A, Spanò A, Calcaterra S, Dianzani F, Antinori A, Capobianchi MR. Abbate I, et al. Among authors: antinori a. Infect Genet Evol. 2005 Apr;5(3):247-53. doi: 10.1016/j.meegid.2004.08.006. Epub 2004 Dec 7. Infect Genet Evol. 2005. PMID: 15737916

8

Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis.

Nardacci R, Antinori A, Larocca LM, Arena V, Amendola A, Perfettini JL, Kroemer G, Piacentini M. Nardacci R, et al. Among authors: antinori a. Am J Pathol. 2005 Sep;167(3):695-704. doi: 10.1016/S0002-9440(10)62044-5. Am J Pathol. 2005. PMID: 16127150 Free PMC article.

9

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.

Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P. Tozzi V, et al. Among authors: antinori a. AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13. doi: 10.1089/aid.2005.21.706. AIDS Res Hum Retroviruses. 2005. PMID: 16131310

10

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.

Antinori A, Perno CF, Giancola ML, Forbici F, Ippolito G, Hoetelmans RM, Piscitelli SC. Antinori A, et al. Clin Infect Dis. 2005 Dec 15;41(12):1787-93. doi: 10.1086/498310. Epub 2005 Nov 10. Clin Infect Dis. 2005. PMID: 16288405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

901 results

Search Page